Failure of omalizumab for treatment of severe adult atopic dermatitis-Reference-Cited by-同舟云学术

Failure of omalizumab for treatment of severe adult atopic dermatitis

Published:2005-08 Issue:2 Volume:53 Page:338-340
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Krathen Richard A.,Hsu Sylvia

Publisher

Elsevier BV

Subject

Dermatology

Reference20 articles.

1. Does the severity of atopic dermatitis correlate with serum IgE levels?;Laske;Pediatr Allergy Immunol,2004

2. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody;MacGlashan;J Immunol,1997

3. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J Allergy Clin Immunol,2001

4. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics;Soler;Eur Resp J,2001

5. Treatment of allergic asthma with monoclonal anti-IgE antibody;Milgrom;N Engl J Med,1999

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases;Journal of the European Academy of Dermatology and Venereology;2024-07-23

2. MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity;Frontiers in Immunology;2024-05-16

3. A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside;Biomedicines;2022-10-25

4. Atopic Dermatitis Biomarkers and the Movement Toward Personalized Treatment;Dermatitis;2021-10

5. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease;Nature Reviews Drug Discovery;2021-08-20